Venus Concept (NASDAQ:VERO) Shares Up 1.6% – Should You Buy?

Venus Concept Inc. (NASDAQ:VERO) rose 1.6% during trading on Friday . The stock traded as high as $0.42 and last traded at $0.39. Approximately 165,537 shares changed hands during mid-day trading, a decline of 64% from the average daily volume of 465,373 shares. The stock had previously closed at $0.38.

Venus Concept Stock Performance

The company has a market capitalization of $2.80 million, a price-to-earnings ratio of -0.05 and a beta of 0.47. The stock’s 50-day moving average price is $0.35 and its 200-day moving average price is $0.50. The company has a debt-to-equity ratio of 2.83, a quick ratio of 1.18 and a current ratio of 1.86.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Venus Concept stock. Masters Capital Management LLC boosted its holdings in Venus Concept Inc. (NASDAQ:VERO) by 100.0% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 666,702 shares of the company’s stock after buying an additional 333,366 shares during the period. Masters Capital Management LLC owned approximately 10.49% of Venus Concept worth $522,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 87.41% of the company’s stock.

About Venus Concept

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.